Antiproliferative activity of 2,3-disubstituted indoles toward apoptosis-resistant cancers cells

被引：11

作者：

Magedov, Igor V. ^{[1
]}

Lefranc, Florence ^{[2
]}

Frolova, Liliya V. ^{[1
]}

Banuls, Laetitia Moreno Y. ^{[3
]}

Peretti, Amanda S. ^{[4
]}

Rogelj, Snezna ^{[4
]}

Mathieu, Veronique ^{[3
]}

Kiss, Robert ^{[3
]}

Kornienko, Alexander ^{[5
]}

机构：

[1] New Mexico Inst Min & Technol, Dept Chem, Socorro, NM 87801 USA

[2] Univ Libre Brussels, Hop Erasme, Serv Neurochirurg, B-1070 Brussels, Belgium

[3] ULB, Fac Pharm, Lab Toxicol, B-1050 Brussels, Belgium

[4] New Mexico Inst Min & Technol, Dept Biol, Socorro, NM 87801 USA

[5] Texas State Univ San Marcos, Dept Chem & Biochem, San Marcos, TX 78666 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2013年 / 23卷 / 11期

关键词：

Cancer; Apoptosis resistance; Indole; Antiproliferative; GLIOMA-CELLS; GLIOBLASTOMA; CHEMOTHERAPY; SURVIVAL; MODELS;

D O I：

10.1016/j.bmcl.2013.03.110

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Many types of cancer, including glioma, melanoma, NSCLC, among others, are resistant to apoptosis induction and poorly responsive to current therapies with propaptotic agents. We describe a series of 2,3-disubstituted indoles, which display cytostatic rather than cytotoxic effects in cancer cells, and serve as a new chemical scaffold to develop anticancer agents capable of combating apoptosis-resistant cancers associated with dismal prognoses. (C) 2013 Elsevier Ltd. All rights reserved.

引用

页码：3277 / 3282

页数：6

共 23 条

[1] Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy
Branle, F
Lefranc, F
Camby, I
Jeuken, J
Geurts-Moespot, A
Sprenger, S
Sweep, F
Kiss, R
Salmon, I
[J]. CANCER, 2002, 95 (03) : 641 - 655
[2] Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis
Brenner, H
[J]. LANCET, 2002, 360 (9340) : 1131 - 1135
[3] In search of a cytostatic agent derived from the alkaloid lycorine: Synthesis and growth inhibitory properties of lycorine derivatives
Evdokimov, Nikolai M.
Lamoral-Theys, Delphine
Mathieu, Veronique
Andolfi, Anna
Frolova, Liliya V.
Pelly, Stephen C.
van Otterlo, Willem A. L.
Magedov, Igor V.
Kiss, Robert
Evidente, Antonio
Kornienko, Alexander
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (23) : 7252 - 7261
[4] Cost of migration: Invasion of malignant gliomas and implications for treatment
Giese, A
Bjerkvig, R
Berens, ME
Westphal, M
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) : 1624 - 1636
[5] Janssen T, 1996, CANCER, V77, P144, DOI 10.1002/(SICI)1097-0142(19960101)77:1<144::AID-CNCR24>3.0.CO
[6] 2-4
[7] Kleihues PCW., 2000, WORLD HLTH ORG CLASS
[8] Natural Polyphenols that Display Anticancer Properties through Inhibition of Kinase Activity
Lamoral-Theys, D.
Pottier, L.
Dufrasne, F.
Neve, J.
Dubois, J.
Kornienko, A.
Kiss, R.
Ingrassia, L.
[J]. CURRENT MEDICINAL CHEMISTRY, 2010, 17 (09) : 812 - 825
[9] Lycorine, the Main Phenanthridine Amaryllidaceae Alkaloid, Exhibits Significant Antitumor Activity in Cancer Cells That Display Resistance to Proapoptotic Stimuli: An Investigation of Structure-Activity Relationship and Mechanistic Insight
Lamoral-Theys, Delphine
Andolfi, Anna
Van Goietsenoven, Gwendoline
Cimmino, Alessio
Le Calve, Benjamin
Wauthoz, Nathalie
Megalizzi, Veronique
Gras, Thierry
Bruyere, Celine
Dubois, Jacques
Mathieu, Veronique
Kornienko, Alexander
Kiss, Robert
Evidente, Antonio
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (20) : 6244 - 6256
[10] Present and potential future issues in glioblastoma treatment
Lefranc, Florence
Sadeghi, Niloufar
Camby, Isabelle
Metens, Thierry
Dewitte, Olivier
Kiss, Robert
[J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (05) : 719 - 732

← 1 2 3 →